APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's disease
Status PubMed-not-MEDLINE Language English Country United States Media electronic
Document type Journal Article, Preprint
Grant support
OT2 OD027060
NIH HHS - United States
OT2 OD027852
NIH HHS - United States
OT2 OD032100
NIH HHS - United States
PubMed
40385391
PubMed Central
PMC12083631
DOI
10.1101/2025.05.07.25327065
PII: 2025.05.07.25327065
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
- Preprint MeSH
Among the more than 90 identified genetic risk loci for late-onset Alzheimer's disease (AD) and related dementias, the apolipoprotein E gene (APOE) ε2/ε3/ε4 polymorphism remains the longstanding benchmark for genetic disease risk with a consistently large effect across studies1-10. Despite this massive signal, the exact mechanisms for how ε4 increases and for how ε2 decreases dementia risk is not well-understood. Importantly, recent trials of anti-amyloid therapies suggest less efficacy and higher risks of severe side effects in s4 carriers11-13, hampering the treatment of those with the highest unmet need. To improve our understanding of the genetic architecture of AD in the context of its main genetic driver, we performed genome-wide association studies (GWASs) stratified by ε4 and ε2 carrier status. Such insights may help to understand and overcome side effects, to impact clinical trial enrolment strategies, and to create the scientific basis for targeted mechanism-driven therapies in neurodegenerative diseases.
Ace Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain
Alzheimer's Centre Reina Sofia CIEN Foundation Madrid Spain
Amsterdam Neuroscience Neurodegeneration Amsterdam The Netherlands
Bristol Medical School University of Bristol Bristol UK
CAEBI Centro Andaluz de Estudios Bioinformáticos Sevilla Spain
Cardiff School of Medicine Cardiff University Cardiff UK
Center for Alzheimer's and Related Dementias National Institute on Aging Bethesda MD USA
Center for Noninvasive Diagnostics TGen Phoenix AZ USA
Centre for Old Age Psychiatric Research Innlandet Hospital Trust Ottestad Norway
Centre for Precision Psychiatry Institute of Clinical Medicine University of Oslo Oslo Norway
Centro de Biología Molecular Severo Ochoa
Clinic of Neurology UH Alexandrovska Medical University Sofia Sofia Bulgaria
Coalition for Aligning Science 5425 Wisconsin Ave 600 Chevy Chase MD 20815 USA
Delft Bioinformatics Lab Delft University of Technology Delft The Netherlands
Departamento de Medicina Facultad de Medicina Universidad de Sevilla Seville Spain
Department for Cognitive Disorders and Old Age Psychiatry University Hospital Bonn Bonn Germany
Department of Biomedical Science Chosun University Gwangju 61452 Republic of Korea
Department of Biomedical Sciences University of Antwerp Antwerp Belgium
Department of Clinical and Experimental Sciences University of Brescia Italy
Department of Clinical Sciences and Community Health University of Milan Milan Italy
Department of Epidemiology ErasmusMC Rotterdam The Netherlands
Department of Geriatric Psychiatry University Hospital of Psychiatry Zürich Zürich Switzerland
Department of Hematology and Stem Cell Transplant Vito Fazzi Hospital Lecce Italy
Department of Medical Genetics Oslo University Hospital Oslo Norway
Department of Medicine and Surgery Unit of Neurology University Hospital of Parma Parma Italy
Department of Molecular Genetics Brain Research Institute Niigata University Japan
Department of Molecular Neuroscience UCL Institute of Neurology London WC1N 3BG U K
Department of Neurology Akershus University Hospital Lørenskog Norway
Department of Neurology and Clinical Neurophysiology Trondheim University Hospital Trondheim Norway
Department of Neurology Hospital Universitario Donostia San Sebastian Spain
Department of Neuroscience Rita Levi Montalcini University of Torino Torino Italy
Department of Neuroscience Università Cattolica del Sacro Cuore Rome Italy
Department of Neurosciences Leuven Brain Institute KU Leuven Leuven Belgium
Department of Neurosurgery Kuopio University Hospital Puijonlaaksontie 2 FI 70210 Kuopio Finland
Department of Psychiatry and Psychotherapy LVR Klinikum Essen University of Duisburg Essen Germany
Department of Psychiatry and Psychotherapy Medical University Vienna Vienna Austria
Department of Psychiatry and Psychotherapy University Medical Center Goettingen Goettingen Germany
Dept of Biomedical Surgical and Dental Sciences University of Milan Milan Italy
Division of Mental Health and Addiction Oslo University Hospital Oslo Norway
Estudios en Neurociencias y Sistemas Complejos CONICET HEC UNAJ
Faculty of Medicine University of Lisbon Portugal
Fundació Docència i Recerca MútuaTerrassa Terrassa Barcelona Spain
Fundación Pública Galega de Medicina Xenómica IDIS Santiago de Compostela Spain
Geriatric Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
German Center for Neurodegenerative Diseases Berlin Germany
German Center for Neurodegenerative Diseases Bonn Germany
German Center for Neurodegenerative Diseases Goettingen Germany
German Center for Neurodegenerative Diseases Magdeburg Germany
German Center for Neurodegenerative Diseases Munich Germany
Haugesund Hospital Department of Research and Innovation Haugesund Norway
Hong Kong Center for Neurodegenerative Diseases InnoHK Hong Kong China
Hospital Universitario Ramon y Cajal IRYCIS Madrid
Institut de Recerca Biomedica de Lleida Lleida Spain
Institute for Regenerative Medicine University of Zürich Switzerland
Institute for Stroke and Dementia Research University Hospital LMU Munich Munich Germany
Institute for Urban Public Health University Hospital of University Duisburg Essen Essen Germany
Institute of Biomedicine University of Eastern Finland Yliopistoranta 1E 70211 Kuopio Finland
Institute of Clinical Medicine Campus Ahus University of Oslo Oslo Norway
Institute of Clinical Medicine Neurosurgery University of Eastern Finland Kuopio Finland
Institute of Health and Society Faculty of Medicine University of Oslo Oslo Norway
Institute of Neurology Catholic University of the Sacred Heart Rome Italy
Instituto de Investigacion Sanitaria 'Hospital la Paz' Madrid Spain
Instituto de Investigación Sanitaria del Principado de Asturias
International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic
IRCCS Fondazione Don Carlo Gnocchi Florence Italy
Karolinska Institutet Center for Alzheimer Research Department NVS Division of ARC Stockholm Sweden
Karolinska University Hospital Theme inflammation and Aging Sweden
KG Jebsen Centre for Neurodevelopmental disorders University of Oslo Oslo Norway
Krembil Brain Institute University Health Network Toronto Ontario Canada
Laboratorio de Genética Hospital Universitario Central de Asturias Oviedo Spain
Luxembourg Centre for Systems Biomedicine University of Luxembourg Esch sur Alzette Luxembourg
Medical Science Department iBiMED Aveiro Portugal
Munich Cluster for Systems Neurology Munich Germany
Networking Research Center on Neurodegenerative Diseases Instituto de Salud Carlos 3 Madrid Spain
Neurodegenerative Diseases Unit Fondazione IRCCS Ca' Granda Ospedale Policlinico Milan Italy
Neurological Tissue Bank Biobanc Hospital Clinic IDIBAPS Barcelona Spain
Neurology Service Marqués de Valdecilla University Hospital Santander Spain
Neurology Unit IRCCS Fondazione Policlinico Universitario A Gemelli Rome Italy
Neurology Unit IRCCS San Gerardo dei Tintori Monza Italy
Neuroscience Center Zurich University of Zurich and ETH Zurich Switzerland
Neurosciences Area Instituto Biodonostia San Sebastian Spain
Norwegian National Advisory Unit on Aging and Health Vestfold Health Trust Tønsberg Norway
Norwegian National Centre for Aging and Health Vestfold Health Trust Tønsberg Norway
Nuffield Department of Population Health University of Oxford Oxford UK
Old Age Psychiatry Department of Psychiatry Lausanne University Hospital Lausanne Switzerland
School of Medicine and Surgery University of Milano Bicocca Monza Italy
SIAT HKUST Joint Laboratory for Brain Science Shenzhen Guangdong 518055 China
Stavanger University Hospital Stavanger Norway
UK Dementia Research Institute School of Medicine Cardiff University Wales UK
Unit of Neurology 5 Neuropathology Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
Unitat de Genètica Molecular Institut de Biomedicina de València CSIC Valencia Spain
Unitat Trastorns Cognitius Hospital Universitari Santa Maria de Lleida Lleida Spain
Université de Lille Inserm CHU Lille Institut Pasteur de Lille Lille France
University of Bordeaux Inserm Bordeaux Population Health Research Center U1219 Bordeaux France
VIB Center for Brain and Disease Research ON5 Herestraat 49 box 602 3000 Leuven Belgium
VIB Center for Molecular Neurology VIB Antwerp Belgium
Zurich Center for Integrative Human Physiology University of Zurich Switzerland
See more in PubMed
Lambert J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics 45, 1452–1458 (2013). PubMed PMC
Jansen I.E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet 51, 404–413 (2019). PubMed PMC
Kunkle B.W. et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51, 414–430 (2019). PubMed PMC
Wightman D.P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nat Genet 53, 1276–1282 (2021). PubMed PMC
de Rojas I. et al. Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores. medRxiv (2020).
Bellenguez C. et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet 54, 412–436 (2022). PubMed PMC
Lambert J.C., Ramirez A., Grenier-Boley B. & Bellenguez C. Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease. Mol Psychiatry 28, 2716–2727 (2023). PubMed PMC
Corder E. et al. Gene Dose of Apolipoprotein E type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families. Science 261, 921–3 (1992). PubMed
Lake J. et al. Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease. Mol Psychiatry 28, 3121–3132 (2023). PubMed PMC
Fernandez-Calle R. et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases. Mol Neurodegener 17, 62 (2022). PubMed PMC
Mintun M.A. et al. Donanemab in Early Alzheimer's Disease. N Engl J Med 384, 1691–1704 (2021). PubMed
van Dyck C.H. et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med 388, 9–21 (2023). PubMed
Sperling R.A. et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med 389, 1096–1107 (2023). PubMed PMC
GTEx Portal (https://www.gtexportal.org/home/snp/rs10131116).
Dutta B. et al. Profiling of the Chromatin-associated Proteome Identifies HP1BP3 as a Novel Regulator of Cell Cycle Progression. Mol Cell Proteomics 13, 2183–97 (2014). PubMed PMC
Al Barashdi M.A., Ali A., McMullin M.F. & Mills K. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). J Clin Pathol 74, 548–552 (2021). PubMed PMC
Kaplan R. et al. Cloning of Three Human Tyrosine Phosphatases Reveals a Multigene Family of Receptor-Linked Protein-Tyrosine-Phosphatases Expressed in Brain. Proc Natl Acad Sci U S A 87, 7000–7004. PubMed PMC
Hoeng J.C. et al. Identification of new human cadherin genes using a combination of protein motif search and gene finding methods. J Mol Biol 337, 307–17 (2004). PubMed
Kang H.-G., Evers M.R., Xia G., Baenziger J.U. & Schachner M. Molecular Cloning and Expression of anN-Acetylgalactosamine-4-O-sulfotransferase That Transfers Sulfate to Terminal and Non-terminal β1,4-LinkedN-Acetylgalactosamine. Journal of Biological Chemistry 276, 10861–10869 (2001). PubMed
Hiraoka N., Misra A., Belot F., Hindsgaul O. & Fukuda M. Molecular cloning and expression of two distinct human N-acetylgalactosamine 4-O-sulfotransferases that transfer sulfate to GalNAcpi-4GlcNAcpi-R in both N- and O-glycans. Glycobiology 11, 495–504 (2001). PubMed
https://www.ncbi.nlm.nih.gov/gene/65121.
The Human Protein Atlas (proteinatlas.org).
Konishi Y. et al. Deficiency of GDNF Receptor GFRalpha1 in Alzheimer's Neurons Results in Neuronal Death. J Neurosci 34, 13127–38 (2014). PubMed PMC
Chen L.Q. et al. Sugar transporters for intercellular exchange and nutrition of pathogens. Nature 468, 527–32 (2010). PubMed PMC
Schweighauser M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310–314 (2022). PubMed PMC
Cruchaga C. et al. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch Neurol 68, 581–6 (2011). PubMed PMC
Van Deerlin V.M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42, 234–9 (2010). PubMed PMC
Shade L.M.P. et al. GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. Nat Genet 56, 2407–2421 (2024). PubMed PMC
Michaelson J.J. et al. Neuronal PAS Domain Proteins 1 and 3 Are Master Regulators of Neuropsychiatric Risk Genes. Biol Psychiatry 82, 213–223 (2017). PubMed PMC
Erbel-Sieler C. et al. Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc Natl Acad Sci U S A 101, 13648–53 (2004). PubMed PMC
Stranahan A.M., Erion J.R. & Wosiski-Kuhn M. Reelin signaling in development, maintenance, and plasticity of neural networks. Ageing Res Rev 12, 815–22 (2013). PubMed PMC
Asanomi Y. et al. A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease. Mol Med 25, 20 (2019). PubMed PMC
Arnaud L. et al. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-kappaB activation. Cell Rep 40, 111200 (2022). PubMed
Jun G. et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21, 108–17 (2016). PubMed PMC
<final supplementary data Bellenguez et al Nature Genetics.pdf>. Nat Genet 54, 412–436 (2022). PubMed PMC
Vitale D. et al. GenoTools: an open-source Python package for efficient genotype data quality control and analysis. G3 (Bethesda) 15(2025). PubMed PMC
Marchini J., Howie B., Myers S., McVean G. & Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39, 906–13 (2007). PubMed
Chang C.C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4(2015). PubMed PMC
Mbatchou J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet 53, 1097–1103 (2021). PubMed
Juliusdottir T. topr: an R package for viewing and annotating genetic association results. BMC Bioinformatics 24, 268 (2023). PubMed PMC
Watanabe K., Taskesen E., van Bochoven A. & Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun 8, 1826 (2017). PubMed PMC
McLaren W. et al. The Ensembl Variant Effect Predictor. Genome Biol 17, 122 (2016). PubMed PMC
de Leeuw C.A., Mooij J.M., Heskes T. & Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 11, e1004219 (2015). PubMed PMC
Wu Y. et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun 9, 918 (2018). PubMed PMC
Zhu Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet 48, 481–7 (2016). PubMed
de Klein N. et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat Genet 55, 377–388 (2023). PubMed PMC